Prominent healthcare organizations, including the American College of Radiology (ACR) and American Medical Association (AMA), have asked Congress to consider certain policy recommendations during its push to protect patients from surprise medical bills.  

Administering specialty drugs in physicians’ offices and patients’ homes instead of in-hospital could improve care and cut healthcare spending in the U.S. by $4 billion each year, according to a Sept. 9 report from UnitedHealth Group.

Kaiser Permanente, a large health system based in California, will be forced to follow the same disclosure laws as other healthcare payers and providers in the state thanks to a new law signed by Gov. Gavin Newsom.

The reputation of the pharmaceutical industry is tanking among U.S. consumers, the latest Gallup poll reveals.

New gene therapies are carrying price tags in the millions, leaving insurers scrambling to figure out how to cover them and offer the treatments to enrollees, according to The Wall Street Journal.

U.S. District Court Judge Richard Leon has approved the $69 billion acquisition of Aetna by CVS Health, he announced in an opinion on Sept. 4.

Medicare Part D overpaid millions of dollars for prescription drugs that should have been covered by the Medicare Part A hospice benefit, according to a recent report from the Office of Inspector General (OIG), which conducted an audit from 2016 payments. In other words, CMS paid twice for the same drugs.

Purdue Pharma, the maker of popular opioid OxyContin, is preparing to file for bankruptcy before the end of September if the company doesn’t reach a settlement over thousands of lawsuits against the company for its role in the opioid abuse epidemic, Reuters reported, citing people familiar with the matter.